Description
PDF Product Sheet NOBIVAC TRICAT TRIO
Composition
Per dose of 1ml :
| Active substances : Lyophilisate | |
| Live attenuated feline caicivirus, strain F9 | > 4.6 log10 PFU1 |
| Live attenuated feline herpes virus type 1, strain G2620A | > 5.2 log10 PFU1 |
| Live attenuatged feline panleukopenia virus, strain MW-1 | >4.3 log10 CCID502 |
| 1PFU | Plaque-forming units |
| 2CCID50 | Cell culture infective dose 50% |
Indications
Active immunisation of cats:
– to reduce the clinical signs caused by infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV),
– to prevent the clinical signs, leucopoenia and virus excretion caused by infection with feline panleukopenia virus (FPLV)
Onset of immunity:
For FCV and FHV: 4 weeks, for FPLV: 3 weeks.
Duration of immunity:
For FCV and FHV: 1 year, for FPLV: 3 years